“opdivo” Archives

in
Entry Author Date Location
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo 01/24/19 New York
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
In a Huge Biopharma Shakeup, Bristol-Myers to Buy Celgene For $74B 01/03/19 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS 10/18/18 New York
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize 10/01/18 National
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison, Honjo 10/01/18 National
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer 08/17/18 New York
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
With Roche Data, Cancer Combos Post First Win Vs. Small Cell Lung Cancer 06/25/18 San Francisco
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down 05/31/18 National
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
For More Lung Cancer Patients, the Promise of No Chemo Looms Larger 04/16/18 National
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace 04/11/18 National
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
For Latest Combo, Merck Bets $394M on Viralytics, Cancer-Fighting Viruses 02/21/18 New York
Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost 02/14/18 New York
Page 1 of 3 next page »